The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Personalized Translational Platform for Biomarker Discovery in Brain Tumors
Official Title: Personalized Translational Platform for Biomarker Discovery in Brain Tumors
Study ID: NCT01240161
Brief Summary: The central hypothesis for this proposal is that multimodal (clinical, imaging, tissue) biomarkers will better predict early brain tumor response to treatments and will be more reliable prognostic markers in patients with malignant brain tumors.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University of California at San Diego, San Diego, California, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Name: Marie Kijewski, PhD
Affiliation: Brigham and Women's Hospital
Role: PRINCIPAL_INVESTIGATOR